Clinical RoundupFree Phase III CheckMate-743 study of Opdivo and Yervoy meets primary OS endpoint in mesothelioma April 24, 2020Vol.46 No.17
Clinical RoundupFree Phase III CheckMate -9ER meets primary PFS endpoint in RCC April 24, 2020Vol.46 No.17
Clinical RoundupFree New targeted agent produces responses in trial with patients with uterine serous carcinoma April 24, 2020Vol.46 No.17
Clinical RoundupFree RVD Therapy shows substantial benefit in large myeloma study April 24, 2020Vol.46 No.17
Clinical RoundupFree Cue Biopharma and Merck to evaluate CUE-101 + Keytruda in head and neck indication April 24, 2020Vol.46 No.17
Clinical RoundupFree Elicio Therapeutics and NCI study ELI-002 mutant KRAS targeting mechanism April 17, 2020Vol.46 No.16
Clinical RoundupFree ACS study: JUUL sales bounced back within weeks of self-imposed flavor ban April 17, 2020Vol.46 No.16
Clinical RoundupFree Chronic stress can impact response to radiation therapy April 17, 2020Vol.46 No.16
Clinical RoundupFree Phase III TNBC ASCENT study to be stopped for compelling efficacy April 10, 2020Vol.46 No.15
Clinical RoundupFree Roswell Park reports extended survival among breast cancer survivors who exercise regularly April 10, 2020Vol.46 No.15
